{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:37:24Z","timestamp":1781015844016,"version":"3.54.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Several observational studies have demonstrated that significantly rising circulating adipokine levels are pervasive in preeclampsia or eclampsia disorder (or preeclampsia toxemia (PET)). However, it remains unclear whether this relationship is causal. In this study, we sought to elucidate the causal effects of circulating adipokine levels on PET.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Summary-level data and independent genetic variants strongly associated with common adipokine molecule (adiponectin, leptin, resistin, sOB-R, and PAI-1) levels were drawn from public genome-wide association study (GWASs). Additionally, the corresponding effects between instrumental variables and PET outcomes were acquired from the FinnGen consortium, including 4,743 cases and 136,325 controls of European ancestry. Subsequently, an inverse-variance weighted (IVW) approach was applied for the principal two-sample Mendelian randomization (MR) and multivariable MR (MVMR) analyses. Various complementary sensitivity analyses were then carried out to determine the robustness of our models.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The results of the IVW method did not reveal any causal relationship shared across genetically predisposed adipokine levels and PET risk (for adiponectin, OR = 0.86, 95% CI: 0.65\u20131.13, <jats:italic>p<\/jats:italic> = 0.274). Additionally, no significant associations were identified after taking into account five circulating adipokines in MVMR research. Complementary sensitivity analysis also supported no significant associations between them. In the reverse MR analysis, genetically predicted PET risk showed a suggestive association with elevating PAI-1 levels by the IVW method (Beta = 0.120, 95% CI: 0.014, 0.227, <jats:italic>p<\/jats:italic> = 0.026). Furthermore, there were no strong correlations between genetic liability to PET and other adipokine levels (<jats:italic>p<\/jats:italic> &amp;gt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our MR study did not provide robust evidence supporting the causal role of common circulating adipokine levels in PET, whereas genetically predicted PET may instrumentally affect PAI-1 levels. These findings suggest that PAI-1 may be a useful biomarker for monitoring the diagnosis or therapy of PET rather than a therapeutic target for PET.<\/jats:p>","DOI":"10.3389\/fgene.2022.935757","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T08:49:55Z","timestamp":1661158195000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Circulating adipokine levels and preeclampsia: A bidirectional Mendelian randomization study"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: A systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/00365513.2021.1938205","article-title":"The role of resistin in early preeclampsia prediction","volume":"81","author":"Banjac","year":"2021","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e13055","DOI":"10.1111\/aji.13055","article-title":"The role of interleukins in preeclampsia: A comprehensive review","volume":"80","author":"Bellos","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3233\/DMA-2011-0772","article-title":"Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia","volume":"30","author":"Bodova","year":"2011","journal-title":"Dis. Markers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","article-title":"Assessing the suitability of summary data for two-sample mendelian randomization analyses using MR-egger regression: The role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.2","article-title":"Guidelines for performing Mendelian randomization investigations","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/sim.4197","article-title":"Bias in causal estimates from Mendelian randomization studies with weak instruments","volume":"30","author":"Burgess","year":"2011","journal-title":"Stat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable mendelian randomization: The use of pleiotropic genetic variants to estimate causal effects","volume":"181","author":"Burgess","year":"2015","journal-title":"Am. J. Epidemiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1067\/mob.2002.122969","article-title":"A longitudinal study of biochemical variables in women at risk of preeclampsia","volume":"187","author":"Chappell","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2572","DOI":"10.1210\/clinem\/dgac048","article-title":"Causal associations between circulating adipokines and cardiovascular disease: A mendelian randomization study","volume":"107","author":"Chen","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/10641955.2014.913615","article-title":"Maternal serum resistin is reduced in first trimester preeclampsia pregnancies and is a marker of clinical severity","volume":"34","author":"Christiansen","year":"2015","journal-title":"Hypertens. Pregnancy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"154172","DOI":"10.1016\/j.metabol.2020.154172","article-title":"The role of serum adipokine levels in preeclampsia: A systematic review","volume":"106","author":"Daskalakis","year":"2020","journal-title":"Metabolism."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1002607","DOI":"10.1371\/journal.pgen.1002607","article-title":"Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: A multi-ethnic meta-analysis of 45, 891 individuals","volume":"8","author":"Dastani","year":"2012","journal-title":"PLoS Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: Genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ijc.33338","article-title":"Circulating adipokine concentrations and risk of five obesity-related cancers: A mendelian randomization study","volume":"148","author":"Dimou","year":"2021","journal-title":"Int. J. Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.12891\/ceog2039.2016","article-title":"The possible role of serum leptin in preeclampsia","volume":"43","author":"Doster","year":"2016","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/10641955.2016.1211676","article-title":"Fibrinolysis parameters in Sudanese women with severe preeclampsia","volume":"35","author":"Elzein","year":"2016","journal-title":"Hypertens. Pregnancy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30, 931 individuals","volume":"2","author":"Folkersen","year":"2020","journal-title":"Nat. Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jcp.37.1.56","article-title":"The fibrinolytic system in pre-eclampsia","volume":"37","author":"Gow","year":"1984","journal-title":"J. Clin. Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"E9408","DOI":"10.3390\/ijms21249408","article-title":"The role of the adipokines in the most common gestational complications","volume":"21","author":"Gutaj","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1177\/1352458521995484","article-title":"The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A mendelian randomization mediation analysis","volume":"27","author":"Harroud","year":"2021","journal-title":"Mult. Scler."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample mendelian randomization: Avoiding the downsides of a powerful, widely applicable but potentially fallible technique","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ajog.2005.06.041","article-title":"The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia","volume":"193","author":"Hendler","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/1933719109332828","article-title":"Circulating and uteroplacental adipocytokine concentrations in preeclampsia","volume":"16","author":"Herse","year":"2009","journal-title":"Reprod. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1055\/s-0038-1648415","article-title":"The predictive value of the hemostasis parameters in the development of preeclampsia","volume":"67","author":"Ho","year":"1992","journal-title":"Thromb. Haemost."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1182\/blood-2012-06-436188","article-title":"Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation","volume":"120","author":"Huang","year":"2012","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00404-015-3659-4","article-title":"Serum levels of leptin and IP-10 in preeclampsia compared to controls","volume":"292","author":"Kalinderis","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/01443615.2017.1286463","article-title":"Markers of obesity and growth in preeclamptic and normotensive pregnant women","volume":"37","author":"Kharb","year":"2017","journal-title":"J. Obstet. Gynaecol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1038\/ncomms10494","article-title":"Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels","volume":"7","author":"Kilpelainen","year":"2016","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s1071-5576(01)00090-9","article-title":"Decreased maternal serum leptin in pregnancies complicated by preeclampsia","volume":"8","author":"Laml","year":"2001","journal-title":"J. Soc. Gynecol. Investig."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s004040000081","article-title":"Serum leptin levels and the severity of preeclampsia","volume":"264","author":"Martinez-Abundis","year":"2000","journal-title":"Arch. Gynecol. Obstet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1471-0528.2009.02453.x","article-title":"Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia","volume":"117","author":"Masuyama","year":"2010","journal-title":"BJOG"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e56907","DOI":"10.1371\/journal.pone.0056907","article-title":"Association of plasminogen activator inhibitor-type 1 (-675 4G\/5G) polymorphism with pre-eclampsia: Systematic review","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41588-020-0631-4","article-title":"Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics","volume":"52","author":"Morrison","year":"2020","journal-title":"Nat. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jri.2004.09.004","article-title":"Peripheral blood concentrations of adiponectin, an adipocyte-specific plasma protein, in normal pregnancy and preeclampsia","volume":"65","author":"Naruse","year":"2005","journal-title":"J. Reprod. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijgo.2007.04.021","article-title":"Reduced plasma adiponectin and elevated leptin in pre-eclampsia","volume":"98","author":"Ouyang","year":"2007","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","article-title":"Efficient design for mendelian randomization studies: Subsample and 2-sample instrumental variable estimators","volume":"178","author":"Pierce","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1373\/clinchem.2006.081372","article-title":"Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia","volume":"53","author":"Purwosunu","year":"2007","journal-title":"Clin. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/molehr\/gaaa061","article-title":"Palmitic acid induces inflammation in placental trophoblasts and impairs their migration toward smooth muscle cells through plasminogen activator inhibitor-1","volume":"26","author":"Rampersaud","year":"2020","journal-title":"Mol. Hum. Reprod."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/HYPERTENSIONAHA.108.115006","article-title":"Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia","volume":"52","author":"Sandrim","year":"2008","journal-title":"Hypertension"},{"key":"B45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/10641950902849850","article-title":"Comparison of serum levels and the placental expression of resistin between patients with preeclampsia and normal pregnant women","volume":"29","author":"Seol","year":"2010","journal-title":"Hypertens. Pregnancy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jtumed.2021.07.003","article-title":"Serum biomarkers for the prediction and diagnosis of preeclampsia: A meta-analysis","volume":"17","author":"Shahid","year":"2022","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41440-019-0376-6","article-title":"The effect of leptin on blood pressure considering smoking status: A mendelian randomization study","volume":"43","author":"Shen","year":"2020","journal-title":"Hypertens. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"14357","DOI":"10.1038\/ncomms14357","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat. Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jri.2006.05.004","article-title":"Selective increase in high molecular weight adiponectin concentration in serum of women with preeclampsia","volume":"73","author":"Takemura","year":"2007","journal-title":"J. Reprod. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.114.03979","article-title":"Serum leptin measured in early pregnancy is higher in women with preeclampsia compared with normotensive pregnant women","volume":"65","author":"Taylor","year":"2015","journal-title":"Hypertension"},{"key":"B51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"597.e1","DOI":"10.1016\/j.ajog.2009.06.024","article-title":"Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia","volume":"201","author":"Wikstrom","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ajhg.2021.05.014","article-title":"Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects","volume":"108","author":"Xue","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"E1651","DOI":"10.3390\/ijms18081651","article-title":"Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases","volume":"18","author":"Ye","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"103490","DOI":"10.1016\/j.jri.2022.103490","article-title":"The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review","volume":"150","author":"Zhai","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/ije\/dyz142","article-title":"Powerful three-sample genome-wide design and robust statistical inference in summary-data Mendelian randomization","volume":"48","author":"Zhao","year":"2019","journal-title":"Int. J. Epidemiol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.935757\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T08:50:00Z","timestamp":1661158200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.935757\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":56,"alternative-id":["10.3389\/fgene.2022.935757"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.935757","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"935757"}}